SeniorJournal.com - Daily News for Senior Citizens

  FRONT PAGE Aging • Health • Alzheimer's - Mental • Nutrition • Medicare & Medicaid Politics  • Fitness  • Social Security • Alerts • Sex Health • Features • Retirement  Elder Care  >Search  >Senior Links

 

Alzheimer's, Dementia & Mental Health

Seniors face high risk of Alzheimer’s, dementia from anticholinergic drugs

Senior citizens often take anticholinergic drugs, which are commonly prescribed for a wide range of common health conditions

Senior woman looking at drugs in medicine cabinetFeb. 17, 2015 – There is nothing that strikes fear in the hearts of senior citizens more than the risk of dementia, and Alzheimer’s disease in particular. A recent study found, however, a significantly increased risk for developing dementia, including Alzheimer’s disease from taking commonly used medications with anticholinergic effects, which are taken frequently by older adults, often unknowingly. They even include nonprescription medicines like Benadryl.

But the stern warning about anticholinergics significantly increasing this risk among seniors failed to get the attention it probably deserves.

Senior citizens often take anticholinergic drugs, which are commonly prescribed for a wide range of health conditions. Among the most widely used anticholinergics are antihistamines, including over-the-counter allergy and cold preparations and sleeping aids used regularly by elderly people.

“Older adults should be aware that many medications - including some available without a prescription, such as over-the-counter sleep aids - have strong anticholinergic effects,” said Shelly Gray, PharmD, MS, the first author of the report.

 

Related Stories

 

 

Mental patients have higher death risk but seldom die from this condition

Approximately 8 million deaths each year, are attributable to mental disorders

Feb. 11, 2015

Meditation may give us more years with healthy brain as we age

Incidence of cognitive decline and dementia has increased substantially as elderly population has grown

Feb. 9, 2015

Read the latest news on Alzheimer's, Dementia & Mental Health

 

And the greater the use of the drugs, the higher the potential risk, according to the researchers.

“Efforts to increase awareness among health care professionals and older adults about this potential medication-related risk are important to minimize anticholinergic use over time,” they said in their conclusion.

“But of course, no one should stop taking any therapy without consulting their health care provider,” said Dr. Gray, who is a professor, the vice chair of curriculum and instruction, and director of the geriatric pharmacy program at the UW School of Pharmacy. “Health care providers should regularly review their older patients’ drug regimens—including over-the-counter medications—to look for chances to use fewer anticholinergic medications at lower doses.”

JAMA Internal Medicine published the online report, called “Cumulative Use of Strong Anticholinergics and Incident Dementia.” The National Institute on Aging (NIA) supported the research.

Anticholinergics are prescribed for many health conditions in older people, including overactive bladder, depression and even just seasonal allergies. Some are available over the counter and are often used as sleep aids. These medications block a neurotransmitter – acetylcholine - in the brain and body and may cause such side effects as impaired cognition, especially in older people. This side effect was previously thought to be reversible once the person stopped taking the medication.

However, the researchers show that these medications may have a lasting impact.

By analyzing records and data from the NIA-supported Group Health/University of Washington Adult Changes in Thought (ACT) study for drugs prescribed over 10 years to 3,434 seniors age 65 and older, they calculated cumulative exposure to drugs with strong anticholinergic effects.

Prospective population-based cohort study using data from the Adult Changes in Thought study in Group Health, an integrated health care delivery system in Seattle, Washington. We included 3434 participants 65 years or older with no dementia at study entry.

Initial recruitment occurred from 1994 through 1996 and from 2000 through 2003. Beginning in 2004, continuous replacement for deaths occurred. All participants were followed up every 2 years. Data through September 30, 2012, were included in these analyses.

During a mean follow-up of 7.3 years, 797 participants (23.2%) developed dementia. Seventy-nine percent of these (637) developed Alzheimer's disease).

The analysis showed that 78 percent of ACT participants used anticholinergics at least once in 10 years.

The higher the use of anticholinergics, the higher the risk of dementia, regardless of whether the drugs had been taken recently or years ago.

The findings suggest that physicians treating older people should prescribe alternatives to anticholinergics, when possible, or lower doses of the drugs. More studies are needed to determine to what extent stopping anticholinergics can reduce the risk of developing permanent dementia.

 “If providers need to prescribe a medication with anticholinergic effects because it is the best therapy for their patient,” Dr. Gray said. “They should use the lowest effective dose, monitor the therapy regularly to ensure it’s working, and stop the therapy if it’s ineffective.”

More about
Anticholinergic Drugs

Are Your Drugs Raising Your Risk for Dementia?

Joe Graedon, The People’s Pharmacy, presents an educated look at this research on anticholinergic drugs. He provides a good analysis of anticholinergic drugs and their uses.

Certain Allergy, Depression Meds Tied to Higher Odds for Dementia

Robert Preidt, HealthDay, presents a more laid back view of the research. -- “However, the study could only point to an association between long-term or high-dose use of these drugs and a higher risk of dementia, it could not prove cause-and-effect.”

  List of reports and information about these drugs at the U.S. government’s National Library of Medicine, Medline Plus website – anticholinergic

 Medicines that people with AD should not take

From booklet “Caring for a Person with Alzheimer’s Disease,” by National Institute on Aging.

Anticholinergic drugs are used to treat many medical problems such as sleeping problems, stomach cramps, incontinence, asthma, motion sickness, and muscle spasms. Side effects, such as confusion, can be serious for a person with AD. These drugs should NOT be given to a person with AD.

 Medicines Used to Treat COPD

By American Thoracic Society

Bronchodilators are medications that relax the muscles that wrap around your breathing tubes, allowing the tubes to become larger and easier to breathe through. Types of bronchodilators include anticholineragics.

Anticholinergic bronchodilators are inhaled medicines.

 List of commonly used drugs with moderate to high anticholinergic properties

By Virginia Commonwealth University

 Alzheimer’s Association links to topics on anticholinergics

Anticholinergic effects happen because some medications block the neurotransmitter called acetylcholine in the brain and body, she explained. That can cause many side effects, including drowsiness, constipation, retaining urine, and dry mouth and eyes.

The study used more rigorous methods, longer follow-up (more than seven years), and better assessment of medication use via pharmacy records (including substantial nonprescription use) to confirm this previously reported link. It is the first study to show a dose response: linking more risk for developing dementia to higher use of anticholinergic medications.

And, it is also the first to suggest that dementia risk linked to anticholinergic medications may persist - and may not be reversible even years after people stop taking these drugs.

“With detailed information on thousands of patients for many years, the ACT study is a living laboratory for exploring risk factors for conditions like dementia,” said Dr. Gray’s coauthor Eric B. Larson, MD, MPH.

“This latest study is a prime example of that work and has important implications for people taking medications—and for those prescribing medications for older patients.” Dr. Larson is the ACT principal investigator, vice president for research at Group Health, and executive director of Group Health Research Institute (GHRI). He is also a clinical professor of medicine at the UW School of Medicine and of health services at the UW School of Public Health.

Some ACT participants agree to have their brains autopsied after they die. That will make it possible to follow up this research by examining whether participants who took anticholinergic medications have more Alzheimer’s-related pathology in their brains compared to nonusers.

Notes:

University of Washington School of Pharmacy

Founded in 1894, the UW School of Pharmacy is ranked #3 in the world according to Shanghai Jiao Tong University. Follow the School of Pharmacy on Facebook or Twitter.

UW Medicine

UW Medicine is part of the University of Washington. Its system includes Harborview Medical Center, Northwest Hospital & Medical Center, Valley Medical Center, UW Medical Center, UW Neighborhood Clinics, UW Physicians, UW School of Medicine and Airlift Northwest. UW Medicine is affiliated with Seattle Children’s, Fred Hutchinson Cancer Research Center, the Veteran’s Affairs Healthcare System in Seattle, and the Boise VA Medical Center. It shares in the ownership and governance of the Seattle Cancer Care Alliance and Children’s University Medical Group.

Group Health Research Institute

Group Health Research Institute does practical research that helps people stay healthy. The Institute is the research arm of Seattle-based Group Health Cooperative, a consumer-governed, nonprofit health care system. Founded in 1947, Group Health Cooperative coordinates health care and coverage. Group Health Research Institute changed its name from Group Health Center for Health Studies in 2009. The Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems since 1983. Government and private research grants provide its main funding. Follow Group Health research on Facebook, Twitter, or YouTube.

Follow on  and 

 

Financial Relief for Volkswagen Diesel Owners

You may be eligible for money damages if you owned or leased one of these VW, Porsche or Audi vehicles.

In the major scandal of 2015, Volkswagen cheated you and the world. They rigged diesel emission controls so you, nor regulators, would know how much pollution their cars were adding to our environment.

They were caught and have reserved $7.3 billion to help "make it right" with victims.

If you owned or leased one of these vehicles, contact us now.

 Beth Janicek, Board Certified Personal Injury Attorney Janicek Law attorneys are actively pursuing these cases against VW. Do Not Wait...

Janicek Law Firm, PC

Free Consultation

(Call toll free)

1-877-795-3425 or Email

Vehicles Involved

VW Jetta (2009–2015)

VW Jetta SportWagen (2009–2014)

VW Golf (2010-2015)

VW Golf SportWagen (2015)

VW Beetle (2012–2015)

VW Passat (2012-2015)

Audi A3 (2010-2015)

VW Touareg (2009–2016)

Porsche Cayenne (2015)

Audi A6, A7, A8, Q5 Quattro (2016)

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Keep up with the latest news for senior citizens, baby boomers

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

 

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, SASeniors.com, DrugDanger.com, etc.